Unraveling the complexities of the Raf/MAP kinase pathway for pharmacological intervention
Author:
Publisher
Elsevier BV
Subject
Molecular Biology,Molecular Medicine
Reference30 articles.
1. The hallmarks of cancer;Hanahan;Cell,2001
2. Growth factor signaling in cell survival: implications for cancer treatment;Talapatra;J. Pharmacol. Exp. Ther.,2001
3. The Raf signal transduction cascade as a target for chemotherapeutic intervention in growth factor-responsive tumors;Weinstein-Oppenheimer;Pharmacol. Ther.,2000
4. Signaling from Ras to Rac and beyond: Not just a matter of GEFs;Scita;EMBO J.,2000
5. Both farnesyltransferase and geranylgeranyltransferase I inhibitors are required for inhibition of oncogenic K-Ras prenylation but each alone is sufficient to suppress human tumor growth in nude mouse xenografts;Sun;Oncogene,1998
Cited by 96 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A Phase II Exploratory Study to Identify Biomarkers Predictive of Clinical Response to Regorafenib in Patients with Metastatic Colorectal Cancer Who Have Failed First-Line Therapy;International Journal of Molecular Sciences;2023-12-19
2. Low entropic cost of binding confers high selectivity on an allosteric ERK2 inhibitor;Bioorganic & Medicinal Chemistry Letters;2023-09
3. The overview of Mitogen-activated extracellular signal-regulated kinase (MEK)-based dual inhibitor in the treatment of cancers;Bioorganic & Medicinal Chemistry;2022-09
4. Identification of a novel target site for ATP-independent ERK2 inhibitors;Biochemical and Biophysical Research Communications;2022-02
5. Biological halogen bonds in protein–ligand complexes: a combined QTAIM and NCIPlot study in four representative cases;Organic & Biomolecular Chemistry;2021
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3